Literature DB >> 11901330

Using the SF-36 for characterizing outcome after multiple trauma involving head injury.

Ellen J MacKenzie1, Melissa L McCarthy, John F Ditunno, Carol Forrester-Staz, Gary S Gruen, Donald W Marion, William C Schwab.   

Abstract

BACKGROUND: The purpose of this study was to evaluate the validity of the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) for examining outcomes after multiple trauma and to investigate whether the addition of items selected to measure cognitive function could improve the sensitivity of the SF-36 for identifying differences in outcomes for patients with and without head injury.
METHODS: One thousand two hundred thirty patients discharged from 12 trauma centers were interviewed 1 year after injury. The interview included the SF-36 supplemented with four items chosen to assess cognitive function.
RESULTS: The resulting cognitive function scale is internally consistent and measures a component of health that is independent of the dimensions incorporated in the SF-36. It correlates well with established measures of brain injury severity and discriminates among patients with and without brain injury.
CONCLUSION: This study underscores the need to supplement the SF-36 with a measure of cognitive function when evaluating outcome from multiple trauma involving head injury. Further studies are needed to validate the specific items chosen for measuring cognitive function.

Entities:  

Mesh:

Year:  2002        PMID: 11901330     DOI: 10.1097/00005373-200203000-00018

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  21 in total

1.  Causes and outcomes of mild traumatic brain injury: an analysis of CIREN data.

Authors:  P Dischinger; K Read; T Kerns; S Ho; J Kufera; C Burch; N Jawed; A Burgess; F Bents
Journal:  Annu Proc Assoc Adv Automot Med       Date:  2003

Review 2.  Evaluation of instruments for measuring the burden of sport and active recreation injury.

Authors:  Nadine E Andrew; Belinda J Gabbe; Rory Wolfe; Peter A Cameron
Journal:  Sports Med       Date:  2010-02-01       Impact factor: 11.136

3.  PTSD after severe vehicular crashes.

Authors:  Gabriel E Ryb; Patricia C Dischinger; Kathleen M Read; Joseph A Kufera
Journal:  Ann Adv Automot Med       Date:  2009-10

4.  Psychometric properties of measures of upper limb activity performance in adults with and without spasticity undergoing neurorehabilitation-A systematic review.

Authors:  Shannon Pike; Anne Cusick; Kylie Wales; Lisa Cameron; Lynne Turner-Stokes; Stephen Ashford; Natasha A Lannin
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

5.  Self-reported health indicators in the year following a motor vehicle crash: a comparison of younger versus older subjects.

Authors:  Daniel Andersen; Gabriel Ryb; Patricia Dischinger; Joseph Kufera; Kathleen Read
Journal:  Ann Adv Automot Med       Date:  2010

6.  Trajectory subtypes after injury and patient-centered outcomes.

Authors:  Ben L Zarzaur; Teresa Bell
Journal:  J Surg Res       Date:  2015-12-30       Impact factor: 2.192

7.  Multisite investigation of traumatic brain injuries, posttraumatic stress disorder, and self-reported health and cognitive impairments.

Authors:  Douglas F Zatzick; Frederick P Rivara; Gregory J Jurkovich; Charles W Hoge; Jin Wang; Ming-Yu Fan; Joan Russo; Sarah Geiss Trusz; Avery Nathens; Ellen J Mackenzie
Journal:  Arch Gen Psychiatry       Date:  2010-12

Review 8.  Systematic review of the literature on pain in patients with polytrauma including traumatic brain injury.

Authors:  Steven K Dobscha; Michael E Clark; Benjamin J Morasco; Michele Freeman; Rose Campbell; Mark Helfand
Journal:  Pain Med       Date:  2009-10       Impact factor: 3.750

9.  Development of a trauma-specific quality-of-life measurement.

Authors:  John Paul Wanner; Terri deRoon-Cassini; Lisa Kodadek; Karen Brasel
Journal:  J Trauma Acute Care Surg       Date:  2015-08       Impact factor: 3.313

10.  Serum cleaved tau does not predict postconcussion syndrome after mild traumatic brain injury.

Authors:  Marek Ma; Christopher J Lindsell; Clark M Rosenberry; George J Shaw; Frank P Zemlan
Journal:  Am J Emerg Med       Date:  2008-09       Impact factor: 2.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.